Rida Zainab (2026) “A Randomized Trial of miRNA-34a-Based Therapy for Chemosensitization in Triple-Negative Breast Cancer Patients”, Journal of Health, Wellness and Community Research, 4(5), pp. 1–7. doi:10.61919/hxwqyv32.